PCI may not improve survival for some heart disease patients

PCI may not improve survival for some heart disease patients
(HealthDay)—Patients with stable ischemic heart disease who undergo percutaneous coronary intervention (PCI) fare no better than those treated with medication and lifestyle changes alone, according to a report published in the Nov. 12 issue of the New England Journal of Medicine.

Researchers looked at the long-term survival of 1,211 patients who took part in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). In that trial, patients were randomly assigned to have PCI plus medication, or receive alone to manage their stable and relieve their angina.

During the 15-year follow-up, 561 patients died: 180 died during the initial four-year follow-up period in the original trial, and 381 died during the remaining follow-up period. Among those who had undergone PCI, 284 patients died. And 277 died in the group treated with medical therapy alone, the researchers reported.

"Patients need to understand what they are getting an angioplasty for," coauthor William Boden, M.D., a professor of medicine at Albany Medical College in New York, told HealthDay. "If they are being told that it's going to reduce the risk of heart attack or it's going make them live longer, they're getting the wrong message."

The study was funded in part by the pharmaceutical industry.


Explore further

Angioplasty procedure reduces need for additional drug even when blockages remain

More information: Abstract
Full Text

Copyright © 2015 HealthDay. All rights reserved.

Citation: PCI may not improve survival for some heart disease patients (2015, November 13) retrieved 17 February 2019 from https://medicalxpress.com/news/2015-11-pci-survival-heart-disease-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
9 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more